13241cobas® HCV - 09040765190 Quantitative nucleic acid test for use on the cobas® 5800/6800/8800 Systems
Albania medical device registration · Roche Molecular Systems, Inc. 1080 US Highway 202 South Branchburg, NJ 08876 USA · Invitro · Model cobas® HCV - 09040765190 Quantitative nucleic acid test for use on the cobas® 5800/6800/8800 Systems · Registered December 14, 2022
- Risk Class
- Invitro
- Product Model
- cobas® HCV - 09040765190 Quantitative nucleic acid test for use on the cobas® 5800/6800/8800 Systems
- Product Name
- cobas® HCV - 09040765190 Quantitative nucleic acid test for use on the cobas® 5800/6800/8800 Systems
- Registration Date
- December 14, 2022
- Analysis ID
- 13241
Test per amplifikimin e acidit nukleik per zbulimin dhe percaktimin sasior te ARN-se te hepatit C
Access comprehensive regulatory information for cobas® HCV - 09040765190 Quantitative nucleic acid test for use on the cobas® 5800/6800/8800 Systems in the Albania medical device market through Pure Global AI's free database. This Invitro medical device is manufactured by Roche Molecular Systems, Inc. 1080 US Highway 202 South Branchburg, NJ 08876 USA. The device was registered on December 14, 2022.
This page provides complete registration details including product model (cobas® HCV - 09040765190 Quantitative nucleic acid test for use on the cobas® 5800/6800/8800 Systems), manufacturer information, risk classification, and regulatory compliance data from the official Albania medical device database. Pure Global AI offers free access to Albania's medical device registry, helping global MedTech companies navigate Albania regulations efficiently.